Plus: treating the whole patient; noninsulin adherence; can Dalcetrapib reduce new-onset diabetes?
Can't see the images? View as webpage.
Facebook
Twitter
LinkedIn
To ensure that you never miss an issue, please whitelist us.

May 26, 2020 : DCMS #503

DISASTERS AVERTED — Near Miss Case Studies


Treating the Whole Patient

TOP STORIES - Diabetes News & Research


Adherence with Noninsulin Medication for Adolescents with Type 1 Diabetes

The Long Term Effects of Early Glycemic Control in Patients with Diabetes

Reducing New-Onset Type Diabetes with Dalcetrapib
Letter from the Editor

Over the past 5 years all of the SGLT-2 inhibitors have gotten various indications for cardiovascular protection. Now it appears that a drug used for Acute Coronary Syndrome can have very positive benefits in preventing and reversing diabetes. Check out this week's feature from Chardae Whitner, 2020 PharmD. Candidate, Lake Erie College of Osteopathic Medicine, on the use of dalcetrapib and its effects on diabetes.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief


Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.

Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.

Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.

Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.

Visit Doctor's Option

DISASTERS AVERTED — Near Miss Case Studies

Treating the Whole Patient
We were running a clinical study on erectile dysfunction. A 68-year-old male with obesity came in looking for help for his ED, so he thought he might qualify for the study. He had not had a medical workup for some time and wasn't aware of any underlying diseases. I recommended he be screened for diabetes....
READ MORE

TOP STORIES - Diabetes News and Research

Adherence with Noninsulin Medication for Adolescents with Type 1 Diabetes
What factors affect adherence for our young patients? 
READ MORE
The Long Term Effects of Early Glycemic Control in Patients with Diabetes
Minimization of secondary diabetic complications from early glycemic control in type 2 diabetes patients.
READ MORE
Reducing New-Onset Type Diabetes with Dalcetrapib
Can cholesteryl ester transfer protein inhibitors reduce incident type 2 diabetes?
READ MORE

MOST POPULAR ARTICLES OF THE MONTH


#1 A1C levels are Indicators of Coronary Atherosclerotic Plaque Formation

#2 Why CGM?

#3 Did You Know? Metformin, along with dozens of drugs, may have promise against COVID-19
 About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
Facebook
Twitter
LinkedIn
©2020 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of:
Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States

DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe